D-serine levels in AD were further studied in 2015 which showed increases in level of D-serine in AD patients with controls and in the experimental models of rats and mice which were developed via intracerebroventricular injections of amyloid B oligomers and APP/PS1 in the latter [35]. The gene discussed is APP; the disease is Alzheimer disease.